Dr Stephanie Kuku
Senior Advisor & Consultant - Health Tech
Dr Stephanie Kuku is a health technology advisor in digital health and artificial intelligence at Hardian Health. Prior to Hardian, Stephanie worked with Spex Capital as an Advisor. Stephanie has had over 15 years clinical and research experience and trained and worked in the NHS/HCA as a surgical oncologist specialising in women's cancers.
Stephanie is also Senior Advisor and Consultant in Clinical AI at the World Health Organisation’s Department of Digital Health & Innovation; deep due diligence and clinical/scientific validation of technology. Further, she is Healthcare Lead for Women in AI (WAI), NHS England Clinical Entrepreneur and Honorary Senior Research Fellow at UCL where she was awarded a Doctorate in Clinical Research in Oncology.
During her clinical career Stephanie sat on council of a National Cancer Society (BGCS) and was awarded numerous International travelling fellowships to; Memorial Sloane Kettering Cancer Center in New York, Cancer Hospital Pernambuco in Brazil, and Centre du Cancer Oscar Lambret in France.
Stephanie often speaks on the validation of health technology and has hosted a US podcast (HLTH) on themes around technology and the future of health.
Stephanie is an angel investor with Alma Angels and sits on a Healthcare investment committee where she advises on deal flow and due diligence.
Listen to one of her latest podcast episodes on the future of health tech.
We are incredibly proud and pleased to have Stephanie as the judge for the Healthcare & Well-being category at our TTI Global Impact Awards.